With the evolving industrialization of life sciences, many companies are looking to capitalize on growth opportunities and pro-actively manage their capital structures. Such objectives often require accessing capital markets in the form of a public offering. Done properly, an IPO not only supports a company's corporate strategy, but also transforms the lives of everyone involved (owners, board, employees and investors).

Please join us on December 6th to hear our group of experts discuss how to best prepare for and execute a successful IPO, as well as adjust to life post-IPO. In this seminar, panelists will explore the current regulatory environment, market trends, the preparation necessary to ensure readiness, as well as the transition and long-term effects of becoming a public company.

Date:
Thursday, December 6, 2018

Location:
Life Sciences Pennsylvania
650 E. Swedesford Road
Suite 190
Wayne, PA 19087

Time:
3:00PM-5:00PM Conference
5:00PM-6:30PM Victory Brewing - Beer & Wine Tasting + Food Pairings

Panelists:
Jeff Ammerman, Managing Director Healthcare Investment Banking, Piper Jaffray & Co.
Rachael Bushey, Partner, Pepper Hamilton
Roberto Cuco, Chief Financial Officer, OraSure
Thomas P. Hess, Chief Financial Officer, Genomind
Carolyn Saacke, COO of Capital Markets, NYSE
Steve Simpson, Partner, EY

Moderators:
Barbara Elias, Managing Director, Donnelley Financial Solutions
Dan Rudio, Managing Director, Pine Hill Group

Register here: https://comms.dfsco.com/LP=2114

A confirmation will be sent upon registration.

Please note this invitation is not transferable.